Expression of Programmed Death-Ligand 1 by Human Colonic CD90+ Stromal Cells Differs Between Ulcerative Colitis and Crohn’s Disease and Determines Their Capacity to Suppress Th1 Cells-Reference-Cited by-同舟云学术

Expression of Programmed Death-Ligand 1 by Human Colonic CD90+ Stromal Cells Differs Between Ulcerative Colitis and Crohn’s Disease and Determines Their Capacity to Suppress Th1 Cells

Published:2018-05-30 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Beswick Ellen J.,Grim Carl,Singh Abinav,Aguirre Jose E.,Tafoya Marissa,Qiu Suimin,Rogler Gerhard,McKee Rohini,Samedi Von,Ma Thomas Y.,Reyes Victor E.,Powell Don W.,Pinchuk Irina V.

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Center for Advancing Translational Sciences

National Institute of Allergy and Infectious Diseases

National Cancer Institute

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference58 articles.

1. Imbalances of CD4(+) T-cell subgroups in Crohn’s disease and their relationship with disease activity and prognosis;Chao;J Gastroenterol Hepatol,2014

2. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases;Strober;Gastroenterology,2011

3. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution;Heller;Gastroenterology,2005

4. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5;Fuss;J Immunol,1996

5. Aberrant responses to TLR agonists in pediatric IBD patients; the possible association with increased production of Th1/Th17 cytokines in response to candida, a luminal antigen;Jyonouchi;Pediatr Allergy Immunol,2010

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity;EMBO Molecular Medicine;2024-04-29

2. Identification of immune cell markers associated with ulcerative colitis histological disease activity in colonic biopsies;Journal of Clinical Pathology;2024-02-28

3. Increased Activity of MAPKAPK2 within Mesenchymal Cells as a Target for Inflammation-Associated Fibrosis in Crohn’s Disease;Journal of Crohn's and Colitis;2024-01-15

4. PD-1-positive cells contribute to the diagnosis of inflammatory bowel disease and can aid in predicting response to vedolizumab;Scientific Reports;2023-12-04

5. Role reversals: non-canonical roles for immune and non-immune cells in the gut;Mucosal Immunology;2023-11